亚洲男人的天堂2018av,欧美草比,久久久久久免费视频精选,国色天香在线看免费,久久久久亚洲av成人片仓井空

Evidence-based medicine promises to improve the quality of healthcare by empowering medical decisions and practices with the best available evidence. The rapid growth of medical evidence, which can be obtained from various sources, poses a challenge in collecting, appraising, and synthesizing the evidential information. Recent advancements in generative AI, exemplified by large language models, hold promise in facilitating the arduous task. However, developing accountable, fair, and inclusive models remains a complicated undertaking. In this perspective, we discuss the trustworthiness of generative AI in the context of automated summarization of medical evidence.

We investigate the potential of patent data for improving the antibody humanness prediction using a multi-stage, multi-loss training process. Humanness serves as a proxy for the immunogenic response to antibody therapeutics, one of the major causes of attrition in drug discovery and a challenging obstacle for their use in clinical settings. We pose the initial learning stage as a weakly-supervised contrastive-learning problem, where each antibody sequence is associated with possibly multiple identifiers of function and the objective is to learn an encoder that groups them according to their patented properties. We then freeze a part of the contrastive encoder and continue training it on the patent data using the cross-entropy loss to predict the humanness score of a given antibody sequence. We illustrate the utility of the patent data and our approach by performing inference on three different immunogenicity datasets, unseen during training. Our empirical results demonstrate that the learned model consistently outperforms the alternative baselines and establishes new state-of-the-art on five out of six inference tasks, irrespective of the used metric.

Collaborative perception aims to mitigate the limitations of single-agent perception, such as occlusions, by facilitating data exchange among multiple agents. However, most current works consider a homogeneous scenario where all agents use identity sensors and perception models. In reality, heterogeneous agent types may continually emerge and inevitably face a domain gap when collaborating with existing agents. In this paper, we introduce a new open heterogeneous problem: how to accommodate continually emerging new heterogeneous agent types into collaborative perception, while ensuring high perception performance and low integration cost? To address this problem, we propose HEterogeneous ALliance (HEAL), a novel extensible collaborative perception framework. HEAL first establishes a unified feature space with initial agents via a novel multi-scale foreground-aware Pyramid Fusion network. When heterogeneous new agents emerge with previously unseen modalities or models, we align them to the established unified space with an innovative backward alignment. This step only involves individual training on the new agent type, thus presenting extremely low training costs and high extensibility. It also protects new agents' model details from disclosure since the training can be conducted by the agent owner locally. To enrich agents' data heterogeneity, we bring OPV2V-H, a new large-scale dataset with more diverse sensor types. Extensive experiments on OPV2V-H and DAIR-V2X datasets show that HEAL surpasses SOTA methods in performance while reducing the training parameters by 91.5% when integrating 3 new agent types. Code and data are available at: //github.com/yifanlu0227/HEAL.

Major depressive disorder (MDD) presents challenges in diagnosis and treatment due to its complex and heterogeneous nature. Emerging evidence indicates that reward processing abnormalities may serve as a behavioral marker for MDD. To measure reward processing, patients perform computer-based behavioral tasks that involve making choices or responding to stimulants that are associated with different outcomes. Reinforcement learning (RL) models are fitted to extract parameters that measure various aspects of reward processing to characterize how patients make decisions in behavioral tasks. Recent findings suggest the inadequacy of characterizing reward learning solely based on a single RL model; instead, there may be a switching of decision-making processes between multiple strategies. An important scientific question is how the dynamics of learning strategies in decision-making affect the reward learning ability of individuals with MDD. Motivated by the probabilistic reward task (PRT) within the EMBARC study, we propose a novel RL-HMM framework for analyzing reward-based decision-making. Our model accommodates learning strategy switching between two distinct approaches under a hidden Markov model (HMM): subjects making decisions based on the RL model or opting for random choices. We account for continuous RL state space and allow time-varying transition probabilities in the HMM. We introduce a computationally efficient EM algorithm for parameter estimation and employ a nonparametric bootstrap for inference. We apply our approach to the EMBARC study to show that MDD patients are less engaged in RL compared to the healthy controls, and engagement is associated with brain activities in the negative affect circuitry during an emotional conflict task.

With the emergence and spread of infectious diseases with pandemic potential, such as COVID- 19, the urgency for vaccine development have led to unprecedented compressed and accelerated schedules that shortened the standard development timeline. In a relatively short time, the leading pharmaceutical companies1, received an Emergency Use Authorization (EUA) for vaccine\prime s en-mass deployment To monitor the potential side effect(s) of the vaccine during the (initial) vaccination campaign, we developed an optimal sequential test that allows for the early detection of potential side effect(s). This test employs a rule to stop the vaccination process once the observed number of side effect incidents exceeds a certain (pre-determined) threshold. The optimality of the proposed sequential test is justified when compared with the ({\alpha}, {\beta}) optimality of the non-randomized fixed-sample Uniformly Most Powerful (UMP) test. In the case of a single side effect, we study the properties of the sequential test and derive the exact expressions of the Average Sample Number (ASN) curve of the stopping time (and its variance) via the regularized incomplete beta function. Additionally, we derive the asymptotic distribution of the relative savings in ASN as compared to maximal sample size. Moreover, we construct the post-test parameter estimate and studied its sampling properties, including its asymptotic behavior under local-type alternatives. These limiting behavior results are the consistency and asymptotic normality of the post-test parameter estimator. We conclude the paper with a small simulation study illustrating the asymptotic performance of the point and interval estimation and provide a detailed example, based on COVID-19 side effect data (see Beatty et al. (2021)) of our suggested testing procedure.

Convolutional neural networks have shown to be widely applicable to a large number of fields when large amounts of labelled data are available. The recent trend has been to use models with increasingly larger sets of tunable parameters to increase model accuracy, reduce model loss, or create more adversarially robust models -- goals that are often at odds with one another. In particular, recent theoretical work raises questions about the ability for even larger models to generalize to data outside of the controlled train and test sets. As such, we examine the role of the number of hidden layers in the ResNet model, demonstrated on the MNIST, CIFAR10, CIFAR100 datasets. We test a variety of parameters including the size of the model, the floating point precision, and the noise level of both the training data and the model output. To encapsulate the model's predictive power and computational cost, we provide a method that uses induced failures to model the probability of failure as a function of time and relate that to a novel metric that allows us to quickly determine whether or not the cost of training a model outweighs the cost of attacking it. Using this approach, we are able to approximate the expected failure rate using a small number of specially crafted samples rather than increasingly larger benchmark datasets. We demonstrate the efficacy of this technique on both the MNIST and CIFAR10 datasets using 8-, 16-, 32-, and 64-bit floating-point numbers, various data pre-processing techniques, and several attacks on five configurations of the ResNet model. Then, using empirical measurements, we examine the various trade-offs between cost, robustness, latency, and reliability to find that larger models do not significantly aid in adversarial robustness despite costing significantly more to train.

In recent years, text summarization methods have attracted much attention again thanks to the researches on neural network models. Most of the current text summarization methods based on neural network models are supervised methods which need large-scale datasets. However, large-scale datasets are difficult to obtain in practical applications. In this paper, we model the task of extractive text summarization methods from the perspective of Information Theory, and then describe the unsupervised extractive methods with a uniform framework. To improve the feature distribution and to decrease the mutual information of summarization sentences, we propose a new sentence extraction strategy which can be applied to existing unsupervised extractive methods. Experiments are carried out on different datasets, and results show that our strategy is indeed effective and in line with expectations.

Influential diagnosis is an integral part of data analysis, of which most existing methodological frameworks presume a deterministic submodel and are designed for low-dimensional data (i.e., the number of predictors p smaller than the sample size n). However, the stochastic selection of a submodel from high-dimensional data where p exceeds n has become ubiquitous. Thus, methods for identifying observations that could exert undue influence on the choice of a submodel can play an important role in this setting. To date, discussion of this topic has been limited, falling short in two domains: (i) constrained ability to detect multiple influential points, and (ii) applicability only in restrictive settings. After describing the problem, we characterize and formalize the concept of influential observations on variable selection. Then, we propose a generalized diagnostic measure, extended from an available metric accommodating different model selectors and multiple influential observations, the asymptotic distribution of which is subsequently establish large p, thus providing guidelines to ascertain influential observations. A high-dimensional clustering procedure is further incorporated into our proposed scheme to detect multiple influential points. Simulation is conducted to assess the performances of various diagnostic approaches. The proposed procedure further demonstrates its value in improving predictive power when analyzing thermal-stimulated pain based on fMRI data.

Understanding causality helps to structure interventions to achieve specific goals and enables predictions under interventions. With the growing importance of learning causal relationships, causal discovery tasks have transitioned from using traditional methods to infer potential causal structures from observational data to the field of pattern recognition involved in deep learning. The rapid accumulation of massive data promotes the emergence of causal search methods with brilliant scalability. Existing summaries of causal discovery methods mainly focus on traditional methods based on constraints, scores and FCMs, there is a lack of perfect sorting and elaboration for deep learning-based methods, also lacking some considers and exploration of causal discovery methods from the perspective of variable paradigms. Therefore, we divide the possible causal discovery tasks into three types according to the variable paradigm and give the definitions of the three tasks respectively, define and instantiate the relevant datasets for each task and the final causal model constructed at the same time, then reviews the main existing causal discovery methods for different tasks. Finally, we propose some roadmaps from different perspectives for the current research gaps in the field of causal discovery and point out future research directions.

We consider the problem of explaining the predictions of graph neural networks (GNNs), which otherwise are considered as black boxes. Existing methods invariably focus on explaining the importance of graph nodes or edges but ignore the substructures of graphs, which are more intuitive and human-intelligible. In this work, we propose a novel method, known as SubgraphX, to explain GNNs by identifying important subgraphs. Given a trained GNN model and an input graph, our SubgraphX explains its predictions by efficiently exploring different subgraphs with Monte Carlo tree search. To make the tree search more effective, we propose to use Shapley values as a measure of subgraph importance, which can also capture the interactions among different subgraphs. To expedite computations, we propose efficient approximation schemes to compute Shapley values for graph data. Our work represents the first attempt to explain GNNs via identifying subgraphs explicitly and directly. Experimental results show that our SubgraphX achieves significantly improved explanations, while keeping computations at a reasonable level.